Maryam Kabootari

Metabolic effects of dopamine-agonists treatment among patients with prolactinomas.

Kabootari M, Shirmohammadli H, Golgiri F, Mosalamiaghili S, Khajavi A, Akbari H.

Endocrine. 2022 Nov 09. PMID: 36352337

Clinical features, risk factors and a prediction model for in-hospital mortality among diabetic patients infected with COVID-19: data from a referral centre in Iran.

Kabootari M, Habibi Tirtashi R, Hasheminia M, Bozorgmanesh M, Khalili D, Akbari H, Roshandel G, Hadaegh F.

Public Health. 2022 Jan. 202:84-92. PMID: 34933204

Radiation-Free myeloablative allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia: A comparison of outcomes between patients with and without central nervous system involvement.

Esfandbod M, Enshaei M, Monzavi SM, Kabootari M, Behfar M, Hamidieh AA.

Leuk Res. 2021 12. 111:106703. PMID: 34534907

Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.

Kabootari M, Asgari S, Ghavam SM, Abdi H, Azizi F, Hadaegh F.

J Transl Med. 2021 06 30. 19(1):277. PMID: 34193200

Usefulness of prolactin measurement in inferior petrosal sinus sampling with desmopressin for Cushing's syndrome.

Akbari H, Ghorbani M, Kabootari M, Mehrjardi AZ, Mohajeri Tehrani MR, Malek M, Khamseh ME.

Br J Neurosurg. 2020 Jun. 34(3):253-257. PMID: 32238018

Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.

Kabootari M, Hasheminia M, Azizi F, Mirbolouk M, Hadaegh F.

Cardiovasc Diabetol. 2020 03 30. 19(1):41. PMID: 32228577

Gestational diabetes mellitus in mothers and long term cardiovascular disease in both parents: Results of over a decade follow-up of the Iranian population.

Kabootari M, Hasheminia M, Guity K, Ramezankhani A, Azizi F, Hadaegh F.

Atherosclerosis. 2019 09. 288:94-100. PMID: 31352273

Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study.

Kabootari M, Akbarpour S, Azizi F, Hadaegh F.

Nutr Metab (Lond). 2019. 16:16. PMID: 30858870

Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study.

Kabootari M, Raee MR, Akbarpour S, Asgari S, Azizi F, Hadaegh F.

BMJ Open. 2018 11 25. 8(11):e023735. PMID: 30478120

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study.

Kabootari M, Asgari S, Mansournia MA, Khalili D, Valizadeh M, Azizi F, Hadaegh F.

J Am Heart Assoc. 2018 02 10. 7(4). PMID: 29440011